A clinical trial to compare atezolizumab plus chemotherapy with chemotherapy alone in people with triple-negative breast cancer (ALEXANDRA/IMpassion030/BIG 16-05/AFT-27).

A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer

Cancer
Breast Cancer
Triple Negative Breast Cancer

Results
Download
Print

Study results

LPS WO39391 IMpassion030 Final Results February 2025 English (PDF, 0.8 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A clinical trial to compare atezolizumab plus chemotherapy with chemotherapy alone in people with triple-negative breast cancer (ALEXANDRA/IMpassion030/BIG 16-05/AFT-27).

Study results

LPS WO39391 IMpassion030 Final Results February 2025 English (PDF, 0.8 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A clinical trial to compare atezolizumab plus chemotherapy with chemotherapy alone in people with triple-negative breast cancer (ALEXANDRA/IMpassion030/BIG 16-05/AFT-27).

For the latest version of this information please go to www.forpatients.roche.com